Cord blood: From bench to bedside;Le sang de cordon: Du laboratoire au lit du malade

Bulletin du Cancer

Volumn 95, Issue 3, 2008, Pages 314-319

  Bron, Dominique ^a   De Bruyn, Cécile ^a   Balasse, H ^b   Ley, P ^b   De Hemptinne, D ^b   Von Lennep, E ^b   Homans, C ^b   Marckowicz, E ^b   Mathieu, P ^b   Deleuse, M D ^b   Francotte, J ^c   Thomas, D ^d   Dorval, C ^a   Dejeneffe, M ^a   Andrien, M ^e   Delforge, A ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b Institut Edith Clavell   (Belgium)

^c CHU Tivoli

^d Hôpital d'Ixelles   (Belgium)

^e Labo HLA   (Belgium)

Author keywords

Cord blood; Hematopoietic; Transplantation

Indexed keywords

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL COUNT; FANCONI ANEMIA; HEMATOPOIETIC STEM CELL; HLA SYSTEM; HUMAN; MESENCHYME CELL; MONONUCLEAR CELL; ORGAN DONOR; REVIEW; UMBILICAL CORD BLOOD;

ADULT; BLOOD BANKS; BLOOD CELL COUNT; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; REFERENCE VALUES; SEX FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 42149107479     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0589     Document Type: Review

References (43)

1. Bay JO, Peffault de Latour R, Tournilhac O, Choufi B, Chassagne JJ. Utilisation des facteurs de croissance hématopoïétiques et transplantation de cellules souches d'origine autologue ou allogénique. Bull Cancer 2006 ; 93 : 473-82.
2. Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974 ; 43 : 357-61.
3. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989 ; 321 : 1174-8.
4. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993 ; 81 : 1679-90.
5. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007 ; 137 : 20-35.
6. Gluckman E. Cord blood transplantation. Biol Blood Marrow Transplant 2006 ; 12 : 808-12.
7. Broxmeyer HE. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 2005 ; 7 : 209-18.
8. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors : analysis of engraftment and acute graft-versus-host disease. Blood 1996 ; 88 : 795-802.
9. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997 ; 337 : 373-81.
10. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998 ; 339 : 1565-77.
11. Kernan NA, Carter SL, Wagner JE, et al. Umbilical cord blood transplantation in pediatric patients : results of the prospective multi institutional Cord Blood Transplantation Study. Biol Blood Marrow Transplant 2006 ; 12 : 14.
12. Bay JO, Cabrespine A. Peffault de Latour. Place des anticorps monoclonaux dans le traitement de la maladie de greffon contre l 'hôte. Bull Cancer 2007 ; 94 : 33-41.
13. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995 ; 346 : 214-9.
14. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996 ; 335 : 157-66.
15. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999 ; 93 : 3662-71.
16. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases : influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002 ; 100 : 1611-8.
17. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, et al. Eurocord Transplant Group. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003 ; 101 : 2137-43.
18. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group ; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004 ; 351 : 2276-85.
19. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004 ; 351 : 2265-75.
20. Gluckman E, Rocha V. Cord blood transplantation for children with acute leukaemia : a Eurocord registry analysis. Blood Cells Mol Dis 2004 ; 33 : 271-3.
21. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia : a comparison study. Lancet 2007 ; 369 : 1947-54.
22. Eapen M. Unrelated donor hematopoietic stem cell transplantation in children with acute leukaemia : risks and benefits of umbilical cord blood versus HLA-A, -B, -C and -DRB1 allele-matched bone marrow. Blood 2006 ; 108 : 133a.
23. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005 ; 105 : 1343-7.
24. Magro E, Regidor C, Cabrera R, Sanjuan I, Fores R, Garcia-Marco JA, et al. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Haematologica 2006 ; 91 : 640-8.
25. Verneris MR, Brunstein C, DeFor TE, et al. Risk of relapse after umbilical cord blood transplantation in patients with acute leukaemia : marked reduction in recipients of two units. Blood 2005 ; 106 : 93a.
26. De Bruyn C, Stryckmans P, Bron D, Ley P, Degueldre M, Delforge A. Modulation of the growth of hematopoietic human stem cells by growth factors : comparison of umbilical cord blood with bone marrow. J Hematother 1993 ; 2 : 241-2.
27. De Bruyn C, Delforge A, Bron D, Ley P, de Hemptinne D, Stryckmans P. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3, IL-6, Granulocyte macrophage-colony stimulating factor and stem cell factor in serum-supplemented and serum-free medium. Stem Cells 1994 ; 12 : 616-25.
28. De Bruyn C, Delforge A, Bernier M, Massy M, De Leeuw N, Bron D, et al. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. Stem Cells 1995 ; 13 : 281-8.
29. De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, de Hemptinne D, et al. Ex vivo expansion of CD34+ CD38- cord blood cells. J Hematother 1997 ; 6 : 93-102.
30. De Bruyn C, Delforge A, Lagneaux L, Bron D. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation. Bone Marrow Transplant 2000 ; 25 : 377-83.
31. De Bruyn C, Delforge A, Bernier M, Bron D. Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells. Cytotherapy 2003 ; 5 : 87-98.
32. De Bruyn C, Delforge A, Bron D. Ex vivo myeloid differentiation of cord blood CD34+ cells : comparison of four serum-free media containing bovine or human albumin. Cytotherapy 2003 ; 5 : 153-63.
33. De Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of megakaryocyte progenitor cells : cord blood versus mobilized peripheral blood. Stem Cells Dev 2005 ; 14 : 415-24.
34. De Bruyn C, Delforge A, Ngirabacu M-C, Bron D. Ex Vivo proliferation and differentiation of CD34 + cells into myeloid progenitor cells : cord blood versus mobilized peripheral blood. Blood 2006 ; 108 : 4175a.
35. Fernandez MN, Regidor C, Cabrera R, Garcia-Marco JA, Fores R, Sanjuan I, et al. Unrelated umbilical cord blood transplants in adults : Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34 + cells from an HLA-haploidentical donor. Exp Hematol 2005 ; 31 : 535-44.
36. Kogler G, Nurnberger W, Fischer J, Niehues T, Somville T, Gobel U, et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 1999 ; 24 : 397-403.
37. Fernandez MN, Granena A, Millan I, Regidor C, Cabrera R, Querol S, et al. Evaluation of engraftment of ex vivo expanded cord blood cells in humans. Bone Marrow Transplant 2000 ; 25 : S61-S67.
38. Pecora AL, Stiff P, Jennis A, Goldberg S, Rosenbluth R, Price P, et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000 ; 25 : 797-9-
39. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002 ; 8 : 368-76.
40. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells : results of a phase 1 trial using the AastromRepli-cell System. Blood 2003 ; 101 : 5061-7.
41. Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, et al. Large-scale expansion and transplantation of CD34+ hematopoietic cells : in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 2006 ; 46 : 1934-42.
42. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000 ; 18 : 307-16.
43. Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004 ; 103 : 1941-8.